China and Middle East underperformance dragged down first-half results, though clinical revenue grew 35 percent year over year.
Oxford Nanopore H1 Prelim Revenue Up 10…
China and Middle East underperformance dragged down first-half results, though clinical revenue grew 35 percent year over year.